Jericho Assisted Living
Tuesday, September 13, 2016
EASD: Benefits of T2D Triple Therapy Hold Up Over Time (CME/CE)
(MedPage Today) -- Three-year follow-up of EDICT trial still supports combo therapy
via
EASD: Benefits of T2D Triple Therapy Hold Up Over Time (CME/CE)
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment